CJC - 1295 ,and IPAMORELIN Research Compound Set (20mg) | 20mg

Hulk Blend 20 mg is a multi‑peptide research formulation presented as a lyophilised vial for controlled analytical and in‑vitro experimentation. It contains two established research peptides — CJC‑1295 and Ipamorelin — enabling researchers to study combined peptide activity, cross‑pathway interactions, and receptor‑signalling behaviour within multi‑compound experimental systems. Each production batch undergoes internal purity verification to ensure suitability for regulated laboratory environments. The formulation brings together two peptides with complementary mechanistic profiles within the growth‑hormone (somatotropic) axis: CJC‑1295, a growth‑hormone‑releasing hormone (GHRH) analogue, for GHRH‑receptor signalling studies; and Ipamorelin, a selective growth‑hormone secretagogue, for ghrelin/GHS‑receptor pathway research. When used in combination, these compounds support exploration of convergent secretagogue signalling, receptor cross‑talk, and dual‑pathway regulatory responses under controlled laboratory conditions.